TSS Receives CDP SME Climate Score 'SME B' for Strong Climate Actions

A technician assembles a temperature data logger.
TSS, a global company specializing in temperature monitoring for the pharmaceutical supply chain, is proud to announce that it has received an 'SME B' rating from the 2024 CDP SME Climate Score. This recognition highlights TSS’s commitment to being open about its environmental impact and taking steps to reduce it.
PRESS RELEASE

The CDP SME Climate Score measures how small and medium-sized businesses manage and share their climate-related information. It follows global standards like the Task Force on Climate-Related Financial Disclosures (TCFD) and IFRS S2 Climate-related Disclosures. Earning an 'SME B' score means that TSS has put strong environmental plans in place and is actively working to lower its carbon footprint.

“At TSS, we believe that sustainability is a key part of the pharmaceutical supply chain’s future,” said Lie Berglind, Chief Quality Officer at TSS. “This recognition from CDP shows that we are making real progress in reducing our environmental impact. Our customers can trust that we are committed to building a greener pharma supply chain. By using data-driven solutions, we continue to improve efficiency and cut emissions.”

TSS will keep working on new sustainability efforts, aligning with global climate goals, and helping customers meet their own environmental targets.

__wf_reserved_inherit

About CDP SME Climate Score

CDP is a global non-profit that runs the world’s only independent environmental disclosure system. As the founder of environmental reporting, we believe in transparency and the power of data to drive change. Partnering with leaders in enterprise, capital, policy and science, we surface the information needed to enable Earth-positive decisions. We helped more than 24,800 companies and 1,100 cities, states and regions disclose their environmental impacts in 2024. Financial institutions with more than a quarter of the world’s institutional assets use CDP data to help inform investment and lending decisions. Aligned with the ISSB’s climate standard, IFRS S2, as its foundational baseline, CDP integrates best-practice reporting standards and frameworks in one place. Our team is truly global, united by our shared desire to build a world where people, planet and profit are truly balanced. Visit CDP.net or follow us @CDP to find out more.

About TSS

TSS is a temperature monitoring and supply chain solutions provider serving the life science and pharmaceutical industry globally. With headquarters in Sweden, TSS have 30 years of experience providing a compliance baseline in hosting GxP Data and GxP validated SaaS to life science companies.

TSS aims to assure safe drugs for every patient by transforming the global pharmaceutical supply chain through an industry leading cloud temperature management solutions. Working in partnership with pharmaceutical companies, TSS provide advanced monitoring and analytics tools to help our client's meet compliance, implement lean and sustainable supply chains, and deliver drugs safely.

Contact

Tobias Holmer
Chief Executive Officer, TSS
tobias.holmer@tss.se

For media inquiries:

Josefin Malmgren
Head of Marketing & Communication, TSS
josefin.malmgren@tss.se

You may also be interested in

A person using a tablet with a high-tech interface, illustrating advanced data analysis for rapid decision-making.

How can maturity in temperature management move your decision process from days to seconds?

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.
Read moreDownload Whitepaper
A scientist using a tablet in a modern laboratory.

On-demand webinar: New approaches to automating temperature management in clinical trials

Temperature excursion management is a prime example of a clinical process that automation can make more efficient. It is currently a highly burdensome activity, where every temperature excursion is evaluated regardless of how minor they are and if they fit well within the excursion budget.
Read moreDownload Whitepaper

Meet Nina Nilsson, Chief Revenue Officer at TSS

We are delighted to officially welcome Nina Nilsson, our new Chief Revenue Officer. Nina is delivering great value to our customers by addressing key pain points, offering insight and understanding which can help to improve our customers business process.
Read moreDownload Whitepaper

You may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.